4.8 Review

The Genetics of Human Schistosomiasis Infection Intensity and Liver Disease: A Review

Journal

FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.613468

Keywords

schistosomiasis; fibrosis; Th17; intensity of infection; QTL; linkage

Categories

Funding

  1. African Academy of Sciences [H3A/18/004]
  2. HIC-Vac, a GCRF Network in Vaccines Research and Development
  3. MRC
  4. BBSRC
  5. European Union
  6. Wellcome Trust [215993/Z/19/Z, 218454/Z/19/Z]
  7. Makerere University-Uganda Virus Research Institute Centre of Excellence for Infection and Immunity Research and Training (MUII) - DELTAS Africa Initiative [107743]
  8. Wellcome Trust [215993/Z/19/Z, 218454/Z/19/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

This review focuses on how genetic factors may influence parasite load, hepatic fibrosis and portal hypertension in schistosomiasis. Studies have shown a potential role for the T(h)17 pathway genes in controlling infection intensity and pathology. Future studies should prioritize investigating the effects of variants in this pathway on regulating these phenotypes.
Schistosomiasis remains the fourth most prevalent parasitic disease affecting over 200 million people worldwide. Control efforts have focussed on the disruption of the life cycle targeting the parasite, vector and human host. Parasite burdens are highly skewed, and the majority of eggs are shed into the environment by a minority of the infected population. Most morbidity results from hepatic fibrosis leading to portal hypertension and is not well-correlated with worm burden. Genetics as well as environmental factors may play a role in these skewed distributions and understanding the genetic risk factors for intensity of infection and morbidity may help improve control measures. In this review, we focus on how genetic factors may influence parasite load, hepatic fibrosis and portal hypertension. We found 28 studies on the genetics of human infection and 20 studies on the genetics of pathology in humans. S. mansoni and S. haematobium infection intensity have been showed to be controlled by a major quantitative trait locus SM1, on chromosome 5q31-q33 containing several genes involved in the T(h)2 immune response, and three other loci of smaller effect on chromosomes 1, 6, and 7. The most common pathology associated with schistosomiasis is hepatic and portal vein fibroses and the SM2 quantitative trait locus on chromosome six has been linked to intensity of fibrosis. Although there has been an emphasis on T(h)2 cytokines in candidate gene studies, we found that four of the five QTL regions contain T(h)17 pathway genes that have been included in schistosomiasis studies: IL17B and IL12B in SM1, IL17A and IL17F in 6p21-q2, IL6R in 1p21-q23 and IL22RA2 in SM2. The T(h)17 pathway is known to be involved in response to schistosome infection and hepatic fibrosis but variants in this pathway have not been tested for any effect on the regulation of these phenotypes. These should be priorities for future studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available